Cited by 184Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Neuromodulation by acetylcholine: examples from schizophrenia and depression

Open access
Higley, Michael J, Picciotto, Marina R·2014·Current Opinion in Neurobiology

Abstract

The contribution of acetylcholine to psychiatric illnesses remains an area of active research. For example, increased understanding of mechanisms underlying cholinergic modulation of cortical function has provided insight into attentional dysfunction in schizophrenia. Acetylcholine normally enhances cortical sensitivity to external stimuli and decreases corticocortical communication, increasing focused attention; however, increases in ACh signaling can lead to symptoms related to anxiety and depression. For example, while stress-induced ACh release can result in adaptive responses to environmental stimuli, chronic elevations in cholinergic signaling may produce maladaptive behaviors. Here, we review several innovations in human imaging, molecular genetics and physiological control of circuits that have begun to identify mechanisms linking altered cholinergic neuromodulation to schizophrenia and depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.conb.2014.06.004

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Impairments to cholinergic signaling in the adult human brain have been linked to psychiatric disorders in adult patients, including schizophrenia, anxiety, and depression.

    “Impairments to cholinergic signaling in the adult human brain have been linked to psychiatric disorders in adult patients, including schizophrenia, anxiety, and depression [101–103].”

    From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [102]

    The schizophrenia section links aberrant acetylcholine signaling to schizophrenia in patients, and the stress and depression section reports altered signaling in depressed patients and anxiety symptoms induced in human subjects. The copy does not establish a link to a diagnosed anxiety disorder in adult patients, nor does it specify that the human subjects were adults. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Higley, M. J., & Picciotto, M. R.
Affiliations
Yale University (US)
Corresponding author
  • Higley, Michael J
  • Picciotto, Marina R
Venue
Current Opinion in Neurobiology
Publisher
Elsevier BV
Published
2014-12
Volume
29
Pages
88-95
ISSN
0959-4388 (ISSN-L)
OpenAlex
W2074521340
Cited by
184
References
92
Citations by year
2026: 14 · 2025: 17 · 2024: 26 · 2023: 19 · 2022: 20 · 2021: 22 · 2020: 12 · 2019: 15 · 2018: 11 · 2017: 8 · 2016: 12 · 2015: 6 · 2014: 2
FWCI
1.14
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (MH099045, MH077681, DA033945, DA014241)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
acetylcholine, cholinergic modulation, schizophrenia, depression, attention, anxiety, cortical function, molecular genetics, human neuroimaging
MeSH terms
Acetylcholine, Anxiety, Attention, Bipolar Disorder, Brain, Humans, Neural Pathways, Schizophrenia, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review